possible link between atypical antipsychotics and diabetes
You'll see more attention on the possible link between atypical antipsychotics and diabetes.
The FDA and drug companies will battle out new label warnings about an increased risk of diabetes for patients on atypicals.
The FDA wants the warnings to apply to ALL atypicals. But some companies don't think the warning applies to their drug.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote